Big Pharma is pushing Big Government mandates in Washington that would hand pharmaceutical companies a massive profit windfall while increasing health care costs for American employers, consumers, and taxpayers.

This Big Pharma scheme, called “delinking,” would remove market-based incentives for pharmacy benefit managers (PBMs) to successfully secure savings on prescription drugs, resulting in more than $39 billion in higher health care costs for the American people, including seniors and families.

Meanwhile, Big Pharma would get a massive $32 billion windfall in the form of higher profits.

A leading economist from The University of Chicago confirmed the Big Pharma windfall would hike costs for consumers and taxpayers while boosting Big Pharma’s profits:

No wonder “delinking” is Big Pharma’s top priority in Washington:

If Big Pharma’s disastrous “delinking” scheme were to pass, it would mean the heavy hand of government directly intervening in the market to tip the scales further in favor of powerful drug companies, boosting their profits, hurting American consumers, and helping politicians on the Left move the country closer to a fully government-controlled socialist health care system.

That’s why leading conservatives, like former U.S. Secretary of State Mike Pompeo, are sounding the alarm on the disastrous implications of this pharma-backed scheme:

Former U.S. Senator Pat Toomey (R-PA) also highlighted the implications of the policy:

Tell your lawmaker to reject higher health care costs for American employers, consumers, and seniors and oppose the Big Pharma “delinking” windfall. Congress should instead focus on increasing competition and allowing the free market to function to lower drug prices, by cracking down on Big Pharma’s out-of-control abuse of the patent system.